COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $67 | -76.9% | 15,694 | -63.0% | 0.01% | -70.4% |
| Q1 2023 | $290 | -99.9% | 42,413 | +106.9% | 0.03% | +42.1% |
| Q3 2022 | $197,000 | -36.0% | 20,500 | -51.8% | 0.02% | -45.7% |
| Q2 2022 | $308,000 | -21.2% | 42,489 | +73.5% | 0.04% | -18.6% |
| Q4 2021 | $391,000 | -32.9% | 24,483 | -38.7% | 0.04% | -34.8% |
| Q1 2021 | $583,000 | +13.9% | 39,924 | +26.4% | 0.07% | -34.0% |
| Q1 2020 | $512,000 | +25.2% | 31,586 | +38.9% | 0.10% | +51.5% |
| Q4 2019 | $409,000 | +17.9% | 22,734 | +32.7% | 0.07% | +8.2% |
| Q3 2019 | $347,000 | +17.6% | 17,128 | -20.8% | 0.06% | +27.1% |
| Q1 2019 | $295,000 | +136.0% | 21,630 | +57.3% | 0.05% | +118.2% |
| Q4 2018 | $125,000 | -78.6% | 13,754 | -61.1% | 0.02% | -72.8% |
| Q3 2018 | $583,000 | +202.1% | 35,343 | +156.0% | 0.08% | +179.3% |
| Q2 2018 | $193,000 | – | 13,805 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |